American Oriental Bioeng (AOB)

American Oriental Bioeng (AOB) Stock Quote Information

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products. The company?s principal prescription pharmaceutical products include Shuanghuanglian Lyophilized Injection Powder (SHL Injection Powder), an anti-viral injection for treating respiratory infections, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel (CE Gel) that is used to alleviate bedwetting. Its over-the-counter pharmaceutical products include Jinji Series, a line of products approved for the treatment of various women?s health indications, including endometritis, annexitis, pelvic inflammation, and premenstrual and menopausal symptoms; Jinji Yimucao, which is used for the treatment of premenstrual syndrome and other PMS and menopause-related symptoms; Cease Enuresis Patch, a product indicated to alleviate bedwetting and for the treatment of incontinence; and Boke Series, a line of nasal products indicated to alleviate sinus infections and nasal congestions. The company also markets various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. American Oriental Bioengineering sells its products primarily to hospitals, clinics, pharmacies, and retail outlets in China through its sales professionals and distributors. The company is based in Beijing, China.